药物对比
Pioglitazone vs Ertugliflozin
比较 Pioglitazone 与 Ertugliflozin 治疗2型糖尿病。TZD 与 SGLT2：胰岛素敏感性、体重/心血管获益、副作用及黑框警告风险，以选择更佳方案。
此页面暂无可用的对比维度。
临床背景
Triggered when adding a second-line agent to metformin in type 2 diabetes patients with obesity, CVD, or insulin resistance.
结论
Ertugliflozin is often preferred for cardiometabolic benefits, but Pioglitazone suits select insulin-resistant cases without heart failure.
全部药物对比